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Objective: There are beneﬁts and risks of giving patients more granular control of their per-
sonal health information in electronic health record (EHR) systems. When designing EHR
systems and policies, informaticists and system developers must balance these beneﬁts and
risks.  Ethical considerations should be an explicit part of this balancing. Our objective was
to  develop a structured ethics framework to accomplish this.
Methods: We reviewed existing literature on the ethical and policy issues, developed an ethics
framework called a “Points to Consider” (P2C) document, and convened a national expert
panel to review and critique the P2C.
Results: We  developed the P2C to aid informaticists designing an advanced query tool for
an  electronic health record (EHR) system in Indianapolis. The P2C consists of six questions
(“Points”) that frame important ethical issues, apply accepted principles of bioethics and
Fair  Information Practices, comment on how questions might be answered, and address
implications for patient care.
Discussion: The P2C is intended to clarify what is at stake when designers try to accommodate
potentially competing ethical commitments and logistical realities. The P2C was  developed
to  guide informaticists who were designing a query tool in an existing EHR that would per-mit  patient granular control. While consideration of ethical issues is coming to the forefront
of  medical informatics design and development practices, more reﬂection is needed to facil-itate optimal collaboratio
discussion.
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.  Introduction
.1.  Access  to  and  control  of  health  information  by
atients
etermining how much information to give to patients about
heir medical care has been the subject of discussion for as
ong as there have been physicians, patients, and medical
nformation. For close to three decades, bioethics scholarship
nd case law reﬂect a deliberate trend toward giving patients
ore  information and more  control over health decision
aking [1]. How much information to give, in what format,
nd by who remains a source of continuing interest, though
2].
With the advent of electronic health records (EHRs), in
hich data are stored electronically, transmitted via regional
ealth information exchanges (HIEs) and accessed by many
roviders and insurers, the idea that within certain limita-
ions patients should be able to control what information is
ade available to physicians has taken on greater urgency
nd complexity. More  data and information about patients –
hich includes test results, genome analyses, prognoses, diag-
oses, prescription patterns, admission or discharge plans –
an be collected, stored, and accessed by more  people than
ver before [3,4].
This potential “tsunami of data” [5] may create several
thical and legal barriers [6], complicated by the different per-
pectives of physicians [7], patients [8], and consumers [9]
bout the proper scope of such control. Indeed, privacy issues
lone are responsible for considerable commentary and reﬂec-
ion [10,11]. For instance, the Health Insurance Portability and
ccountability Act (HIPAA) stipulates numerous uses and dis-
losures of health information that do not require patient
uthorization (e.g., for treatment, payment, and health care
perations) that could result in the disclosure of information
o dozens of recipients [12].
Asking patients to consider disclosure of information for all
otential recipients/uses could prove overwhelming to them
nd detrimental to the health care system. For example, a
atient might wish to restrict her cardiologist from seeing
nformation regarding prior psychiatric treatment, or an indi-
idual who abuses pain killers might wish to block access by
is family doctor to information about previous drug abuse
r concurrently prescribed controlled medications. Patients
ight believe they have good reasons for exercising control
iven the selective history of discrimination in health care
13–15]. Whether the reasons are defensible or not, there are
onsequences, particularly for physicians to safely prescribe
edications.
.2.  Ethical  issues  in  the  use  of  health  information
echnology
he purported beneﬁts to patients and society from the use
f health information technology have been well documented
16,17] though these beneﬁts come with profound logistical,
olicy, and ethical challenges [18,19]. While some ethical guid-
nce exists for using these new tools, gray areas remain,
articularly at the intersection of personal health information o r m a t i c s 8 2 ( 2 0 1 3 ) 1136–1143 1137
and decision making [20]. Indeed, while it has recently been
argued that it might be as ethically blameworthy not to apply
such tools as it would be to apply them inappropriately [21],
the available policy tools are not yet nuanced enough to guide
ethical decision making. For example, the Health Informa-
tion Technology for Economic and Clinical Health (HITECH)
Act [22] includes additional privacy and security requirements
over those mandated by HIPAA [23], but does not specify the
scope of patient control. The President’s Council of Advisors on
Science and Technology (PCAST) 2010 report raised this point
when it discussed, among other things, the need for “innate,
strong, privacy protection on all data, both at rest and in tran-
sit, with persistent patient-controlled privacy preferences. . .”
[24]. PCAST also recognized that there are risks of patients’
exercising unbridled granular control of the information in the
EHR.
Developers of EHR systems and policies, therefore, must
balance the beneﬁts of granular control by patients with the
risks of clinical harm to patients. Support for the idea of giving
patients “granular” control also emerged from the U.S. Ofﬁce of
the National Coordinator for Health Information Technology
(ONC), which indicated that patients should have a “greater
degree of choice to determine, at a granular level, which per-
sonal health information should be shared with whom,  and
for what purpose” [25].
1.3.  Bioethics  principles  and  fair  information  practices
The idea of granular control is a logical application of
many well-accepted ethical principles including respect for
autonomy, beneﬁcence, non-maleﬁcence and justice [26]. For
example, the argument for giving patients greater autonomy
in decision making about medical treatment and research
builds on developments over the past three decades aimed
at supporting patient empowerment and informed choice
[27–29]. At the same time, the argument for restricting the
scope of control follows from a long tradition of benevolent
paternalism in medicine [30]. Thus, granular control ﬁts within
the fundamental interest that individuals have in informa-
tional privacy, which is generally exercised, at least in part,
through the ability to limit access by others to personal infor-
mation [3]. Providing this type of control may be seen to
re-balance the relationship between clinician and patient,
to promote trust, and to enhance overall quality of care
[31–33].
Similarly, granular control is a logical application of Fair
Information Practices (FIPs), described originally in a 1973
report of the Department of Health, Education and Welfare’s
Secretary’s Advisory Committee on Automated Personal Data
Systems [34], and which have evolved over time [35]. The nine
FIPs as described by the ONC are: individual access, correc-
tion, openness and transparency, individual choice, collection,
use and disclosure limitation, data quality and integrity, safe-
guards, and accountability. Indeed, many  versions of FIPs exist
in the US (e.g., the Federal Trade Commission’s FIPs, the ONC
HIT FIPs), in countries other than the US (e.g., Canada’s FIPs),
and in non-national organizations (e.g., the Madrid Privacy
Declaration [36]).
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2.  Background
2.1.  Accommodating  patient  control
In its 2010 report, PCAST asserted that “The overarching goal
is to have a national health IT ecosystem in which every
consumer, doctor, researcher, and institution has appropri-
ate access to the information they need, and in which these
groups are served by a vibrant market of innovators.” They
went on to identify a set of mid-term goals for achieving this
overarching goal including:
“(1) Universal access by clinicians and patients to the cur-
rent frontier of EHR functionality; (2) A robust platform for
developers to create user interfaces, decision support, stor-
age, and archiving services that will be broadly available to
end-users and will not require major capital investments;
(3) Seamless, user-transparent, cross-organizational data
exchange; (4) Innate, strong privacy protection on all data,
both at rest and in transit; and (5) Efﬁcient means for
the aggregation of de-identiﬁed data for public health and
research purposes.” [24].
In 2011, ONC funded several projects to study key com-
ponents of EHR systems, one of which was awarded to
investigators at the Regenstrief Institute and the Indiana Uni-
versity School of Medicine. The overall goal of the project
was to focus on PCAST’s mid-term goals 3–5 (above) by cre-
ating a system within an EHR browser that would restrict
access to patient data based on patient preferences, the iden-
tity of the user, and metadata describing each EHR element.
Providing both greater patient choice in information shar-
ing and more  precise querying by physicians can provide a
means for balancing clinician access to key information and
patients’ desires for conﬁdentiality, especially concerning sen-
sitive data [8].
The environment in which this work took place was
unique: the state of Indiana has a “real world” health infor-
mation exchange that has been operating for over 15 years.
The Indiana Network for Patient Care (INPC) includes more
than 100 hospitals, clinics, public health departments, labo-
ratories, radiology centers, physician practices, pharmacies,
urgent visit centers, and payers, involving more  than 12 mil-
lion patients and 20,000 Indiana providers [37,38].
This project was designed as a collaborative effort involving
experts in informatics, ethics, human factors, and medicine
to combine three key components to support the ethical
and user acceptability of the query tools: the application
of Fair Information Practice Principles, the application of
a human factors approach, and the development of an
ethics framework to guide the design of the user interface.
This manuscript focuses on the third product, the ethics
framework.
A common locus of many  bioethics discussions about
management of patient information is the emphasis on the
clinical encounter between physicians and patients. Little
attention, however, has been given to the upstream work
being undertaken by experts responsible for designing EHRs,
databases, query tools and other infrastructure to enable
patients and physicians to make use of the potential for n f o r m a t i c s 8 2 ( 2 0 1 3 ) 1136–1143
EHRs. Fortuitously, the Regenstrief Institute, whose faculty
designed and were modifying the query tools and patient
data browser for the INPC, and the Indiana University Cen-
ter for Bioethics, whose faculty were designing the ethics
framework, worked in the same building and had a prior his-
tory of research partnerships, enabling productive and regular
collaboration.
3.  Approach
3.1.  The  ethics  framework/Points  to  Consider  for
system  designers
Our goal was to produce an ethics framework to guide those
designing EHRs intended to accommodate granular control.
We settled on a “Points to Consider” document (P2C), an instru-
ment that we  and others have used elsewhere [39–41] because
it can be used both to identify issues and guide decisions
about complex ethical, regulatory, and policy choices. The P2C
consists of a set of key questions that frame an important
technical (or ethical) problem, and a commentary reﬂecting
on the factors that might help answer the question. The
idea, borrowed from one of the ﬁrst P2C’s designed to help
researchers respond to difﬁcult ethical issues in recombinant
DNA research [42], is for those using the P2C to attempt to
answer the questions, and in so doing gain a deeper appreci-
ation of the ethical tradeoffs.
We assembled an internal team with expertise in philos-
ophy, ethics, patient privacy, clinical medicine, and health
policy to conceptualize the project and design the P2C. Given
the emphasis of this project on an ethics framework our team
did not include a legal scholar. However, we  were mindful of
the many  legal and regulatory issues arising and for that rea-
son commissioned a separate paper on the subject [43]. We
met  regularly with health informaticists and computer sci-
ence experts at Regenstrief to share progress and solicit input
– a process that occurred over nine months until a consen-
sus document was produced. The draft P2C was circulated to
an outside panel of national experts brought together for a
one-day workshop in Indianapolis on February 29, 2012. Eleven
individuals with backgrounds in law, health policy, technology,
bioethics, patient privacy, advocacy and government regu-
lations provided substantive comments on the content of
the P2C and its potential usefulness, but were not asked
to endorse or approve the ﬁnal document (see Appendix).
Additional input was sought from others who  could not
attend the expert panel meeting, as well as ONC program
ofﬁcials.
4.  ResultsBelow we provide a brief summary of the ﬁnal P2C. A full
report describing the process we used, more  extended dis-
cussions of each point, and related material is available at:
http://hdl.handle.net/1805/2936 [44].
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.1.  The  Points  to  Consider
. How will the system make transparent the uses and ﬂows
of clinical information so that patients can make informed
choices about disclosing/restricting their information? This
point encompasses at least three interconnected issues:
• How will patients be told about the ﬂows, uses, and users
of their health information?
• How will patients learn what information is contained
in their EHR so they can appreciate what they are grant-
ing access to – a prerequisite for individual choices to be
meaningful?
• How will patients be assisted in understanding the
meaning of the medical information in their EHR (e.g.,
terminology used in pathology, laboratory, and radiolog-
ical tests/reports)?
This point highlights the need to help patients under-
stand what information exists in their EHR, who can view
it, and how this information is used and disclosed, to
allow them to make an informed choice about granular
control. Without such understanding, the opportunity to
exercise granular control is impossible. While the main
focus of this point is on the FIP of openness and trans-
parency, we  recognize that achieving that transparency will
involve educating patients about these topics. This issue is
also addressed in P2C #3, below. Three ethically defensible
options exist:
i. Provide no education regarding what information
exists in the EHR or the ﬂow and uses of informa-
tion besides the required, and fairly general, Notice of
Privacy Practices. Patients will utilize whatever addi-
tional understanding they happen to have, including
any misunderstanding, in exercising granular control.
ii. Provide educational materials for patients to review
before exercising granular control. These materials can
be more  or less speciﬁc or customizable to the literacy
and interests of different patients.
iii. Give all patients access to a trained educator or practi-
tioner who  can brief or tutor them on the EHR.
. How will the system structure the array of choices patients
can specify for disclosure and non-disclosure of their
clinical information?
This point asks designers to consider the many  different
ways that the choices for granular control can be struc-
tured and presented to the patient. First, this involves
determining the level of granularity of the medical data
involved. At one end of the spectrum, patients could be
presented with the option of allowing or limiting access
to each individual data element, such as a speciﬁc lab
result or the clinical note relating to a single visit. The
advantage of offering choices at this level of granularity
is that it allows the individual to exert ﬁne control. The
disadvantage is the overwhelming number and variety of
observations recorded in most EHRs. At the other end of the
spectrum, the patient may be presented with only broad
categories of data, such as being able to restrict access to
all data relating to a single diagnosis (e.g. diabetes), date of
service, person (e.g., clinicians, non-clinicians), treatment o r m a t i c s 8 2 ( 2 0 1 3 ) 1136–1143 1139
(e.g., prescription medications), area of medical care (e.g.,
data relating to endocrinology), and/or sensitivity of the
data (e.g., reproductive health, mental health, substance
abuse, or genetic information). It might be simpler for at
least some patients to comprehend choices at these coarser
levels of granularity.
A similar range of granularity might apply to determina-
tions regarding potential recipients of the data: the system
could allow patients to determine access for individual
clinicians, perhaps identiﬁed by name, or could allow
broader choices, such as determining access for clinicians
from an entire institution or specialty. Similar categories
could be developed for non-clinicians (ofﬁce staff, billing
clerks, etc.).
Finally, one could allow variable levels of granularity:
some patients might wish to make decisions at a ﬁne
level of granularity, regarding data or providers, while oth-
ers would prefer a coarser level. While this would provide
the highest level of patient choice, it also would introduce
another level of complexity to the decisions the patient
would face and a level of complexity in educating the
patient adequately to make an informed choice. It would
also dictate the kinds and levels of metadata EHR deve-
lopers would use to tag observations. Another option is
for patients to choose a less granular standardized choice
from a limited menu  of options but could make requests
for restrictions at ﬁner levels as needed.
3. How will technologically and/or medically unsophisticated
patients, or those with other challenges, exercise their
choices for granular control of their information?
This point considers issues of technological and medical
literacy, as well as standard literacy, and the need to accommo-
date patients of varying physical/sensory abilities. Educating
patients about these topics will be challenging, since it will
require explaining medical science and terminology at least
to some degree, as well as helping patients understand the
range of providers who may be involved in their care who
might be aided by information in the EHR. It may not be possi-
ble to make a system equally accessible, and their data equally
understandable, for all individuals. Therefore, there exists an
ethical obligation to ensure that a patient’s capacity to exercise
granular control is not dependent on their ability to read/speak
English, be ﬂuent in medical terminology, and/or be able to
use a computer. Creative and practical methods will need to
be considered to provide assistance to individuals with chal-
lenges in exercising access controls.
Because the overall goal is to allow patients to express and
record their information-sharing preferences, it is important
that the options for doing so span a reasonably broad range
of patient capabilities. In this case, that may mean that the
system should be designed to accommodate various input
methods. For instance, the system could:• Provide an electronic input option for choices to be recorded
by the patient (and/or his representative) only, and be avail-
able in a variety of languages (at least English and Spanish);
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• Devise a two-step process for input, giving patients a paper
form containing the choices available, which is then taken
by a medical staff member to be recorded in the electronic
system;
• Provide other means for patients to learn about their options
and indicate their preferences, for instance through discus-
sion with a medical staff member (e.g., for those who have
difﬁculty reading, or are sight-challenged) who would then
record the patient’s choices and preferences.
4. How will the system inform providers of a patient’s prefer-
ences for data access/restrictions?
This point acknowledges that providers also have a stake
in the exercise of patient granular control. Fundamentally,
the question asks whether a provider should be alerted in
some way (e.g., by a notation in the EHR) that a patient
has restricted access to at least some part of their EHR.
Any answer has direct implications for the doctor/patient
relationship, both in terms of trust and in the ability to ade-
quately render care. For instance, while it is possible that
most patients would want their primary care physician to
have access to most or all of their medical record for clinical
purposes, patients might prefer that medical specialists or
allied medical professionals (e.g., an orthopedist or a phar-
macist at the local drugstore) have less than full access to
the entire record, for any number of reasons.
While there may be practice issues that result from a
provider having restricted EHR access, it is also true that
this is largely the way in which providers practice medicine
today – seldom does a single provider have full access to all
of a patient’s data, electronic or otherwise. The question
becomes whether to inform providers that information has
been restricted at the behest of the patient. Three options
may be considered:
• When a physician views the patient’s EHR, the system
will specify which information exists and is accessible,
and which information exists but is being restricted due
to the patient’s prior preferences and privacy settings.
• When a physician views the patient’s EHR, the system
will only display the information that is allowed by
the privacy settings, without disclosing the existence of
other information that is subject to access restrictions.
• When a physician views the patient’s EHR, a broad state-
ment that information has been restricted would be
provided without specifying which types of information
are not accessible.
5. Under what circumstances/conditions will the system
allow health care providers to access patient data in ways
that may over-ride stated preferences for granular control?
This point addresses access in emergency, life-threatening
situations, although the prospect of non-emergency situ-
ations in which providers might want to override patient
preferences also are addressed. Health care providers
accept responsibility for the health and wellbeing of their
patients and may feel that having less than full access to
a patient’s information will inhibit their ability to care for
that patient or even cause harm. Options range from never n f o r m a t i c s 8 2 ( 2 0 1 3 ) 1136–1143
allowing overriding of patient preferences to allowing over-
riding of patient preferences in non-emergency situations.
If overriding of patients’ preferences is allowed, then the
system should require the provider to justify the override,
and this information should be stored in the patient’s
record. In this way, we  mean to convey that the act of
overriding a patient’s access preferences is not something
to be taken lightly, particularly in a non-life-threatening
situation. Additionally, whatever approach a provider takes
to the patient’s expressed access preferences, patients
should be informed before such a circumstance might arise
in which preferences are overridden. This is consistent
with the ethical principle of respect for patient autonomy.
6. How will patients be told about mandatory reporting
requirements (e.g., public health, gunshots, abuse, disease
registries, etc.) and their impact on granular control?
This point addresses the issue of mandatory reporting
requirements for public health. Federal and state laws
require that medical information pertaining to a possible
criminal activity (e.g., child abuse or neglect, domestic vio-
lence, and gunshot wounds) be reported to the appropriate
authorities. Similarly, when a patient with a communi-
cable disease presents for treatment (whether for that
condition or something unrelated), state and/or federal
laws/regulations often require reporting of identiﬁable
health information about the disease. Because of this,
patients will not be able to exert granular control on such
information. Any system of granular control must antici-
pate and address this issue.
In these instances, patients have no choice as to whether
providers disclose their information to others, so the ques-
tion addressed is the extent to which patients are informed
of the types of situations requiring information reporting,
the level of speciﬁcity about which they are told of the
information that is reported, and the potential vehicle used
to convey this information. For instance, would general
information on the nature of the potential disclosures be
conveyed to patients via treatment consent statements or
posters at clinical intake areas, or might patients be given
explicit information that, in the case of a sexually trans-
mitted disease for example, their name, address, infection
status, and sexual partners’ names and addresses would
be reported to public health ofﬁcials? While more  speciﬁc
information is deferential to respect for patient autonomy,
a small minority of patients might avoid seeking treat-
ment, knowing that the information will be reported to
the appropriate authorities. However, if a provider suspects
a particular patient might not seek treatment, he or she
may wish, in exceptional cases, to withhold information
about the speciﬁc nature of the disclosures required. Three
options exist:
• Do not explicitly inform patients regarding legally man-
dated reporting requirements (i.e., that irrespective of
her desire to restrict disclosure, some circumstances
mandate disclosures).
•  Provide a general explanation that there may be legal
reasons why some personal health information must be
disclosed, but do not detail those reasons. This could
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include, for example, putting posters in patient intake
areas in clinics, physicians’ ofﬁces, hospitals, outpatient
facilities, etc., or very general statements in Notices of
Privacy Practices given to patients.
• Inform patients more  speciﬁcally what sort of situations
would require disclosure of personal health informa-
tion to public health authorities and/or law enforcement
(e.g., STIs, communicable diseases, epidemic and/or
pandemic outbreaks, abuse, gunshots, suspected bioter-
rorism), and what sort of information would be disclosed
(e.g., name, address, diagnosis, etc.).
.  Discussion
.1.  Use  of  the  P2C
he P2C was developed to guide Regenstrief Institute infor-
aticists who  were designing a query tool for an existing
HR that would permit patient granular control. Identifying
thical issues is an inherent part of designing and implemen-
ing any technology [45], and EHRs are no different [46]. While
very institution is different, one can envision the use of this
2C as a valuable tool for engaging informatics experts, clini-
ians, administrators, patient groups and health care teams in
mportant discussions about these emerging issues in patient
are. Given the scope for interpretation of the each “point” it
s sensible to imagine that systems designers and clinicians
ight sit down to work through each of the points to deter-
ine how and to what extent the points were applicable to the
nstitutional environment in which such issues arise. These
iscussions could come in the form of broader institutional
iscussions, policy deliberations or as the subject of in-service
ducational activities.
While consideration of ethical issues is coming to the
orefront of medical informatics design and development
ractices, more  reﬂection is needed to facilitate optimal col-
aboration between designers and ethicists [47]. Rather than
roviding Regenstrief designers with a ﬁnished ethics frame-
ork, the ethics team met  regularly with the query tool
esigners, presented updated versions of the P2C, and worked
ogether on the design of the INPC’s patient granular control
ystem. Unlike most traditional ethics consultation programs
or clinicians [48] or researchers [49], our intention here was
ot to identify and address a particular ethical challenge
acing a person or team. Rather it was to build ethical con-
iderations into the design process of a query tool from the
tart. That helped the designers keep the implications for Fair
nformation Practices and other patient-centered issues front
nd center when programming the technical aspects of cap-
uring and implementing patients’ preferences for viewing of
heir EHRs.
We  recognized that the use of the P2C should not be limited
o the initial designs of the query tool. As with P2C’s that have
een used for evaluative purposes [50] this P2C can be used
o assess how responsive the query tool is to the six Points,
oth in its initial instantiation and through its inevitable
odiﬁcations. P2Cs should not, therefore, be viewed as a “one
ime only” tool, but should continue to be used as part of ongo-
ng monitoring, evaluation, and redesign processes. Indeed, o r m a t i c s 8 2 ( 2 0 1 3 ) 1136–1143 1141
this may be the real value for various institutions: to use the
P2C as an opportunity to start an informed conversation about
ethical issues with various stakeholders.
Finally, this document examines granular control in the
clinical context, and does not explicitly consider the myriad
additional issues that arise from secondary uses of EHRs (as
deﬁned by HIPAA as uses beyond treatment, payment, and
health care operations) including quality improvement and
cost-containment activities, research [51], or public health
[21]. These warrant separate study and analysis.
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Summary points
What was known before the study?
• There is longstanding ethical support for giving
patients more  autonomy in their health decision mak-
ing, though it has not yet translated into control of
EHRs.
• U.S. policy supports deployment of EHRs but literature
says little about how to build ethics into the upstream
design of EHR systems.
• Bioethics principles have not been merged with Fair
Information Practices.
What has the study added to the body of knowledge?
• Developed an ethics Points to Consider that incorpo-
rates bioethics principles and FIPs for accommodating
patient and clinician considerations in EHR design.
r• Illustrates the potential value of a P2C using an existing
collaboration designers and ethicists.
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